Nimesulide induced Stevens Johnson syndrome (SJS); managed successfully with combined approach of steroids, intravenous immunoglobulin and placentrex gel: A case report
There is a high mortality rate in Stevens Johnson Syndrome (SJS) and it ranges between 5%-15%. At present, there is no definite consensus regarding treatment in SJS although the effectiveness of intravenous immunoglobulin’s (IVIg) and immunosuppressive like cyclosporine have generated new hopes in t...
Main Authors: | Rakesh Tilak Raj, Baljinder Kaur, Krishan Kumar Lochan, Rakesh Kumar Bahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Our Dermatology Online
2014-10-01
|
Series: | Nasza Dermatologia Online |
Subjects: | |
Online Access: | http://www.odermatol.com/issue-in-html/2014-4-12-nimesulide/ |
Similar Items
-
Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap
by: Prabhat Kumar, et al.
Published: (2016-03-01) -
The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis
by: Parag Kisave, et al.
Published: (2020-01-01) -
Factors predicting the outcome of stevens–Johnson syndrome and toxic epidermal necrolysis: A 5-year retrospective study
by: Vishal Thakur, et al.
Published: (2021-01-01) -
Performance of the SCORTEN in Taiwanese patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Yu-Ling Ho, et al.
Published: (2010-03-01) -
A study on adverse drug reactions in a tertiary care hospital of Northeast India
by: Ratan J. Lihite, et al.
Published: (2017-06-01)